Atara aktie
WebApr 11, 2024 · Atara Biotherapeutics (ATRA) Reports Q4 Loss, Misses Revenue Estimates. Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -18.03% and … WebIm Jahr 2024 hat Atara Biotherapeutics 0,00€ ausgeschüttet. Atara Biotherapeutics schüttet keine Dividende aus. In 2024 wurde bisher keine Dividende ausgeschüttet. ... Aktie. US0465131078. A1166A. ATRA. Atara Biotherapeutics. Ins Portfolio Zur Watchlist. Übersicht ...
Atara aktie
Did you know?
WebDec 7, 2024 · Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. With our lead program in Phase 3 clinical development, Atara is the most advanced ... WebNov 8, 2024 · About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease. With our lead program receiving a CHMP …
WebATARA BIOTHERAPEUTICS AKTIE Schätzungen Prognosen & Erwartungen A1166A. Tesla A1CX3T Deutsche Bank 514000 BASF BASF11 TUI TUAG50 Volkswagen (VW) … WebAtara Biotherapeutics Aktie 20 Jahre Umsatz, Dividende, Realtime-Kurs, EBIT, Gewinn, Ausschüttungsquote, Nettoverschuldung und die besten Aktienanalysen.
WebFeb 9, 2024 · Atara is a cell therapy focused biotech with a unique approach based on a novel allogeneic Epstein-Barr virus (EBV) T-cell platform. The company secured the first ever approval of an allogeneic ... WebVärde för Atara Biotherapeutics Inc (symbol: ATRA) i realtid, tekniska analyser, investering, värde och information om finansmarknad från Capital. ... Resultat per aktie efter utspädning exklusive extraordinära poster -0.85653-0.90929-0.90451-0.95795-0.8747: Dividends per Share - Common Stock Primary Issue 0: 0: 0: 0:
WebWerbung Atara Biotherapeutics-Aktie für 0 Euro handeln bei finanzen.net zero 07.11.22 finanzen.net Ausblick: Atara Biotherapeutics öffnet die Bücher zum abgelaufenen Quartal
WebZacks. Atara Biotherapeutics, Inc. develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States. Its lead product … the hanger golf training aidWebFeb 28, 2024 · Atara believes that its cash as of December 31, 2024, together with the anticipated $100.0 million payable to Atara upon closing of the strategic transaction with FDB, will be sufficient to fund ... thehanger golf swing training aid reviewsWebJan 26, 2024 · Published: Jan 26, 2024. Fujifilm to Acquire Atara’s Cell Therapy Manufacturing Facility for Total Upfront Financial Consideration of USD 100 Million. Parties to Enter Long-Term Supply Agreement for Clinical and Commercial Product Manufacturing. Transaction Expected to Result in Reduced Operating Expenses for Atara. the battery phoenix apartmentsWebGet the latest Atara Biotherapeutics Inc (ATRA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. thehanger golf swing training aidWebAtara Biotherapeutics, Inc. er involveret i udvikling af transformative terapier til patienter med alvorlige sygdomme, herunder solide tumorer, hæmatologiske kræftformer og autoimmune sygdomme. Selskabets produkter i pipeline omfatter Tab-cel og ATA188 samt ATA2271, ATA3271 og ATA3219 under CAR T Programmer. the battery peopleWebJan 10, 2024 · About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for ... the battery parking atlantaWebFeb 27, 2024 · Recently, Atara sold a redundant cell manufacturing facility to Fuji, which earned them $100mn in cash. A major recent news that crashed the stock was the death of a patient in its CAR-T program ... the battery place national city